Immix Biopharma, Inc. (NASDAQ:IMMX) Financings

Immix Biopharma, Inc.

Financings

RaiseDate
Public offering of common stock
Announced: US$125M · US$11 a share · J.P. Morgan
Dealers: J.P. Morgan (lead)
Buyers: Eventide Asset Management; Janus Henderson Investors; Ridgeback Capital Investments L.P.; Wellington Management
Use of proceeds: Fund NXC-201 development, working capital and general corporate purposes
Sep 29, 2026
Public offering of common stock and pre-funded warrants
Announced: US$100M · US$5.1 a share · Morgan Stanley +2
Dealers: Morgan Stanley (lead), Citizens Capital Markets, Mizuho
Use of proceeds: Fund NXC-201 development, working capital and general corporate purposes
Dec 7, 2025
Strategic investment of strategic investment
Closed: strategic investment
Buyers: Goose Capital; Dr. Nancy T. Chang
Sep 8, 2025

Read by 6ix AI from the company's releases